Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation.
Iron overload could promote the generation of free radicals and result in deleterious cellular damages. A physiological increase of oxidative stress has been observed in pregnancy. A routine iron supplement, especially a combined iron and vitamin C supplementation, without biological justifications (low hemoglobin [Hb] and iron stores) could therefore aggravate this oxidative risk. We investigated the effect of a daily combined iron supplementation (100 mg/d as fumarate) and vitamin C (500 mg/d as ascorbate) for the third trimester of pregnancy on lipid peroxidation (plasma TBARS), antioxidant micronutriments (Zn, Se, retinol, vitamin E, (beta-carotene) and antioxidant metalloenzymes (RBC Cu-Zn SOD and Se-GPX). The iron-supplemented group (n = 27) was compared to a control group (n = 27), age and number of pregnancies matched. At delivery, all the women exhibited normal Hb and ferritin values. In the supplemented group, plasma iron level was higher than in the control group (26.90 +/- 5.52 mmol/L) and TBARs plasma levels were significantly enhanced (p < 0.05) (3.62 +/- 0.36 vs 3.01 +/- 0.37 mmol/L). No significant changes were observed in plasma trace elements and red blood cell antioxidant metalloenzymes. Furthermore, the alpha-tocopherol plasma level was lowered in the iron-supplemented groups, suggesting an increased utilization of vitamin E. These data show that pharmalogical doses of iron, associated with high vitamin C intakes, can result in uncontrolled lipid peroxidation. This is predictive of adverse effects for the mother and the fetus. This study illustrates the potential harmful effects of iron supplementation when prescribed only on the assumption of anemia and not on the bases of biological criteria.
Lachili
B
B
Faculty of Medicine, Batna University, Algerie.
Hininger
I
I
Faure
H
H
Arnaud
J
J
Richard
M J
MJ
Favier
A
A
Roussel
A M
AM
D000328:Adult; D000975:Antioxidants / Q000378:metabolism; D001034:Apgar Score; D001205:Ascorbic Acid / Q000009:adverse effects*; D019587:Dietary Supplements / Q000009:adverse effects*; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D005293:Ferritins / Q000097:blood; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007231:Infant, Newborn; D007501:Iron / Q000009:adverse effects* / Q000097:blood; D015227:Lipid Peroxidation / Q000187:drug effects*; D011247:Pregnancy / Q000378:metabolism*
D000975:Antioxidants; D006454:Hemoglobins; D005293:Ferritins; D007501:Iron; D001205:Ascorbic Acid